|
US3663606A
(en)
*
|
1966-06-21 |
1972-05-16 |
Mitsui Toatsu Chemicals |
Organic imino-compounds
|
|
DE2363459A1
(de)
|
1973-12-20 |
1975-06-26 |
Basf Ag |
Neue fluoreszierende chinolinverbindungen
|
|
DE3248043A1
(de)
|
1982-12-24 |
1984-06-28 |
Bayer Ag, 5090 Leverkusen |
Fluorogene phosphorsaeureester, verfahren zu deren herstellung sowie verfahren und mittel zum nachweis und zur fluorometrischen bestimmung von phosphaten
|
|
US4659657A
(en)
*
|
1982-12-24 |
1987-04-21 |
Bayer Aktiengesellschaft |
Chromogenic and fluorogenic esters for photometric or fluorimetric determination of phosphatases or sulphatases
|
|
DE3634066A1
(de)
|
1986-10-07 |
1988-04-21 |
Boehringer Mannheim Gmbh |
Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
|
|
JPH07121937B2
(ja)
|
1987-03-18 |
1995-12-25 |
大塚製薬株式会社 |
カルボスチリル誘導体
|
|
JPH0699497B2
(ja)
|
1987-04-16 |
1994-12-07 |
富士写真フイルム株式会社 |
光重合性組成物
|
|
GB8709448D0
(en)
|
1987-04-21 |
1987-05-28 |
Pfizer Ltd |
Heterobicyclic quinoline derivatives
|
|
DE3932953A1
(de)
*
|
1989-10-03 |
1991-04-11 |
Boehringer Mannheim Gmbh |
Neue 2-bicyclo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
GB9107742D0
(en)
|
1991-04-11 |
1991-05-29 |
Rhone Poulenc Agriculture |
New compositions of matter
|
|
GB9108369D0
(en)
|
1991-04-18 |
1991-06-05 |
Rhone Poulenc Agriculture |
Compositions of matter
|
|
GB9108547D0
(en)
|
1991-04-22 |
1991-06-05 |
Fujisawa Pharmaceutical Co |
Quinoline derivatives
|
|
US5710158A
(en)
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5409930A
(en)
|
1991-05-10 |
1995-04-25 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
USRE37650E1
(en)
*
|
1991-05-10 |
2002-04-09 |
Aventis Pharmacetical Products, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5480883A
(en)
*
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5856115A
(en)
*
|
1991-05-24 |
1999-01-05 |
Fred Hutchinson Cancer Research Center |
Assay for identification therapeutic agents
|
|
JP3142378B2
(ja)
|
1992-06-22 |
2001-03-07 |
ティーディーケイ株式会社 |
有機ｅｌ素子
|
|
US5330992A
(en)
*
|
1992-10-23 |
1994-07-19 |
Sterling Winthrop Inc. |
1-cyclopropyl-4-pyridyl-quinolinones
|
|
US5792771A
(en)
*
|
1992-11-13 |
1998-08-11 |
Sugen, Inc. |
Quinazoline compounds and compositions thereof for the treatment of disease
|
|
US5763441A
(en)
*
|
1992-11-13 |
1998-06-09 |
Sugen, Inc. |
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
|
|
US5981569A
(en)
*
|
1992-11-13 |
1999-11-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
|
|
JPH0743896A
(ja)
|
1993-07-28 |
1995-02-14 |
Toyobo Co Ltd |
光重合性組成物
|
|
AU5881394A
(en)
|
1994-01-08 |
1995-08-01 |
Rhone-Poulenc Agriculture Limited |
Benzimidazolyl quinoline-3-carboxylate derivatives, intermediates thereto, and their use as herbicides
|
|
JPH0829973A
(ja)
|
1994-07-11 |
1996-02-02 |
Toyobo Co Ltd |
光重合性組成物
|
|
JP3441246B2
(ja)
|
1995-06-07 |
2003-08-25 |
富士写真フイルム株式会社 |
光重合性組成物
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
EP0888310B1
(en)
|
1996-03-15 |
2005-09-07 |
AstraZeneca AB |
Cinnoline derivatives and use as medicine
|
|
DE19610723A1
(de)
|
1996-03-19 |
1997-09-25 |
Bayer Ag |
Elektrolumineszierende Anordnungen unter Verwendung von Blendsystemen
|
|
CA2258728C
(en)
*
|
1996-06-19 |
2011-09-27 |
Rhone Poulenc Rorer Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
|
HUP9904567A3
(en)
|
1996-06-20 |
2001-10-29 |
Univ Texas |
Use of azo, thioalkyl, thiocarbonyl derivatives substituted by fused heterocycles and/or phenyl group for the preparation of pharmaceutical compositions stimulating bone growth
|
|
KR100567649B1
(ko)
|
1996-09-25 |
2006-04-05 |
아스트라제네카 유케이 리미티드 |
혈관 내피 성장 인자와 같은 성장 인자의 효과를 억제하는 퀴놀린 유도체
|
|
US6245760B1
(en)
|
1997-05-28 |
2001-06-12 |
Aventis Pharmaceuticals Products, Inc |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
WO1999010349A1
(en)
|
1997-08-22 |
1999-03-04 |
Zeneca Limited |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
|
DE19756235A1
(de)
*
|
1997-12-17 |
1999-07-01 |
Klinge Co Chem Pharm Fab |
Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
|
|
CA2312953A1
(en)
|
1998-03-31 |
1999-10-07 |
Warner-Lambert Company |
Quinolones as serine protease inhibitors
|
|
CA2328893A1
(en)
|
1998-05-20 |
1999-11-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Vegf activity inhibitors
|
|
KR100581199B1
(ko)
|
1998-06-19 |
2006-05-17 |
카이론 코포레이션 |
글리코겐 신타제 키나제 3의 억제제
|
|
CA2333647A1
(en)
|
1998-06-29 |
2000-01-06 |
Dupont Pharmaceuticals Company |
Cyclic carbamates and isoxazolidines as iib/iiia antagonists
|
|
FR2781218B1
(fr)
|
1998-07-15 |
2001-09-07 |
Lafon Labor |
Compositions pharmaceutiques comprenant des 2-quinolones
|
|
US6174912B1
(en)
*
|
1998-08-21 |
2001-01-16 |
Dupont Pharmaceuticals Company |
Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists
|
|
DE19841985A1
(de)
|
1998-09-03 |
2000-03-09 |
Schering Ag |
Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate
|
|
WO2000020400A1
(en)
|
1998-10-05 |
2000-04-13 |
Axys Pharmaceuticals, Inc. |
Novel compounds and compositions for treating hepatitis c infections
|
|
IL126953A0
(en)
|
1998-11-08 |
1999-09-22 |
Yeda Res & Dev |
Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
|
|
KR100373203B1
(ko)
|
1999-03-31 |
2003-02-25 |
주식회사 엘지화학 |
새로운 큐마린계 착물 및 이를 이용한 유기 발광 소자
|
|
DE60026297T2
(de)
|
1999-05-21 |
2006-11-02 |
Bristol-Myers Squibb Co. |
Pyrrolotriazin kinasehemmer
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6423734B1
(en)
|
1999-08-13 |
2002-07-23 |
The Procter & Gamble Company |
Method of preventing cancer
|
|
KR100298572B1
(ko)
*
|
1999-08-19 |
2001-09-22 |
박찬구 |
카바아닐라이드로부터 4-니트로디페닐아민과 4-니트로소디페닐아민의 제조방법
|
|
AU778042B2
(en)
*
|
1999-10-19 |
2004-11-11 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
HRP20020349A2
(en)
*
|
1999-10-19 |
2004-02-29 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
EP1248642A4
(en)
|
2000-01-18 |
2005-05-18 |
Ludwig Inst Cancer Res |
PEPTIDOMIMETIC INHIBITOR OF VEGF-D / VEGF-C / VEGF
|
|
CN1307303C
(zh)
|
2000-01-19 |
2007-03-28 |
帕卡什·S·吉尔 |
针对反义vegf寡核苷酸的方法和组合物
|
|
GB0001930D0
(en)
|
2000-01-27 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
US6420382B2
(en)
|
2000-02-25 |
2002-07-16 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6313138B1
(en)
*
|
2000-02-25 |
2001-11-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
AU778417B2
(en)
|
2000-02-25 |
2004-12-02 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2002020500A2
(en)
*
|
2000-09-01 |
2002-03-14 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
|
EP1313734B1
(en)
*
|
2000-09-01 |
2009-11-11 |
Novartis Vaccines and Diagnostics, Inc. |
Aza heterocyclic derivatives and their therapeutic use
|
|
US20030028018A1
(en)
|
2000-09-11 |
2003-02-06 |
Chiron Coporation |
Quinolinone derivatives
|
|
CZ304344B6
(cs)
|
2000-09-11 |
2014-03-19 |
Novartis Vaccines & Diagnostics, Inc. |
Chinolinonový derivát a jeho použití a farmaceutický prostředek s obsahem tohoto derivátu
|
|
CA2422916A1
(en)
|
2000-09-26 |
2002-04-04 |
The University Of Arizona Foundation |
Compounds and methods for use thereof in the treatment of cancer or viral infections
|
|
AU2002226877B2
(en)
|
2000-10-17 |
2006-01-12 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
|
US6693125B2
(en)
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
US7064215B2
(en)
*
|
2001-07-03 |
2006-06-20 |
Chiron Corporation |
Indazole benzimidazole compounds
|
|
EP1447405A4
(en)
|
2001-10-17 |
2005-01-12 |
Kirin Brewery |
CHINOLIN OR CHINAZOLINE DERIVATIVES THAT PREVENT THE AUTOPHOSPHORYLATION OF RECEPTORS FOR THE FIBROBLAST GROWTH FACTOR
|
|
CA2496164C
(en)
*
|
2002-08-23 |
2010-11-09 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
|
US7825132B2
(en)
*
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
US20050256157A1
(en)
*
|
2002-08-23 |
2005-11-17 |
Chiron Corporation |
Combination therapy with CHK1 inhibitors
|
|
EP1545529A4
(en)
|
2002-09-30 |
2010-03-03 |
Bristol Myers Squibb Co |
NEW TYROSINE KINASE HEMMER
|
|
AU2003290699B2
(en)
*
|
2002-11-13 |
2009-08-27 |
Novartis Vaccines And Diagnostics, Inc. |
Methods of treating cancer and related methods
|
|
US7189716B2
(en)
|
2003-01-03 |
2007-03-13 |
Bristol-Myers Squibb Company |
Tyrosine kinase inhibitors
|
|
WO2004063170A1
(en)
*
|
2003-01-09 |
2004-07-29 |
University Of Delhi |
A process for the synthesis of bisbenzimidazoles and its derivations
|
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
|
CN102225926A
(zh)
*
|
2003-11-07 |
2011-10-26 |
诺华疫苗和诊断公司 |
具有改进药物特性的喹啉酮类化合物的药学上可接受的盐
|
|
US7875624B2
(en)
*
|
2004-02-20 |
2011-01-25 |
Novartis Vaccines And Diagnostics, Inc. |
Modulating and measuring cellular adhesion
|
|
JP5545925B2
(ja)
*
|
2005-05-17 |
2014-07-09 |
ノバルティス アーゲー |
ヘテロ環化合物の合成方法
|